| Literature DB >> 26779153 |
Jin-Yu Yang1, Peng Wang1, Chun-Yang Li1, Sheng Dong1, Xiao-Yan Song1, Xi-Ying Zhang1, Bin-Bin Xie1, Bai-Cheng Zhou2, Yu-Zhong Zhang1, Xiu-Lan Chen1.
Abstract
Bacterial extracellular peptidases are important for bacterial nutrition and organic nitrogen degradation in the ocean. While many peptidases of the M13 family from terrestrial animals and bacteria are studied, there has been no report on M13 peptidases from marine bacteria. Here, we characterized an M13 peptidase, PepS, from the deep-sea sedimentary strain Shewanella sp. E525-6, and investigated its substrate specificity and catalytic mechanism. The gene pepS cloned from strain E525-6 contains 2085 bp and encodes an M13 metallopeptidase. PepS was expressed in Escherichia coli and purified. Among the characterized M13 peptidases, PepS shares the highest sequence identity (47%) with Zmp1 from Mycobacterium tuberculosis, indicating that PepS is a new member of the M13 family. PepS had the highest activity at 30°C and pH 8.0. It retained 15% activity at 0°C. Its half life at 40°C was only 4 min. These properties indicate that PepS is a cold-adapted enzyme. The smallest substrate for PepS is pentapeptide, and it is probably unable to cleave peptides of more than 30 residues. PepS prefers to hydrolyze peptide bonds with P1' hydrophobic residues. Structural and mutational analyses suggested that His531, His535 and Glu592 coordinate the catalytic zinc ion in PepS, Glu532 acts as a nucleophile, and His654 is probably involved in the transition state stabilization. Asp538 and Asp596 can stablize the orientations of His531 and His535, and Arg660 can stablize the orientation of Asp596. These results help in understanding marine bacterial peptidases and organic nitrogen degradation.Entities:
Keywords: M13 metallopeptidase; catalytic mechanism; deep-sea bacteria; enzymatic characterization; expression and purification
Year: 2016 PMID: 26779153 PMCID: PMC4701951 DOI: 10.3389/fmicb.2015.01498
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The primers used to amplify pepS and its mutants in this study.
| Primer name | Primer sequence (5′-3′) |
|---|---|
| pepS-F | CGC |
| pepS-R | CCG |
| E532A_a1595c | GCGGTAATTGGACATGCGATGGGCCATGGGTTT |
| E532A_R | AAACCCATGGCCCATCGCATGTCCAATTACCGC |
| D538N_g1612a | GATGGGCCATGGGTTTAATGACCAAGGTGCGA |
| D538N_R | TCGCACCTTGGTCATTAAACCCATGGCCCATC |
| E592D_a1776t | GCGAACTGACACTAGGTGATAACATTGGTGATCTATCTG |
| E592D_R | CAGATAGATCACCAATGTTATCACCTAGTGTCAGTTCGC |
| D596E_t1788g | TAGGTGAAAACATTGGTGAGCTATCTGGTGTGACTATCG |
| D596E_R | CGATAGTCACACCAGATAGCTCACCAATGTTTTCACCTA |
| D596A_a1787c | CTAGGTGAAAACATTGGTGCTCTATCTGGTGTGACTATC |
| D596A_R | GATAGTCACACCAGATAGAGCACCAATGTTTTCACCTAG |
| H654A_c1960g_a1961c_ | TGTGGCCACCGATCCAGCTTCACCCGCTAAGTTC |
| H654A_R | GAACTTAGCGGGTGAAGCTGGATCGGTGGCCACA |
| R660K_c1978a_g1979a_c1980g | CATTCACCCGCTAAGTTCAAGTCGCTGGGCGCCC |
| R660K_R | GGGCGCCCAGCGACTTGAACTTAGCGGGTGAATG |
Effect of ions on the activity of PepS.
| Metal ion | Relatively activity (%) | Metal ion | Relatively activity (%) | ||
|---|---|---|---|---|---|
| 2 mM | 4 mM | 2 mM | 4 mM | ||
| Control | 100.0a | 100.0 | Li+ | 40.4 ± 2.4 | 46.4 ± 2.1 |
| Mg2+ | 105.0 ± 2.3 | 108.0 ± 1.8 | Mn2+ | 38.8 ± 1.3 | 22.6 ± 1.2 |
| Ca2+ | 105.0 ± 1.8 | 95.0 ± 0.9 | Co2+ | 37.1 ± 0.7 | 56.5 ± 2.3 |
| K+ | 60.4 ± 1.3 | 52.2 ± 0.5 | Cu2+ | 31.0 ± 0.7 | 40.7 ± 0.6 |
| Sr2+ | 75.5 ± 0.9 | 25.7 ± 0.8 | Zn2+ | 31.0 ± 1.8 | 16.0 ± 0.4 |
| Ba2+ | 58.4 ± 2.4 | 76.2 ± 1.4 | Sn2+ | 15.1 ± 0.4 | 0 |
Effect of inhibitors on the activity of PepS.
| Inhibitor | Residual activity (%) |
|---|---|
| Control | 100.0a |
| PMSF (2 mM) | 74.1 ± 1.3 |
| EDTA (2 mM) | 21.9 ± 0.7 |
| EGTA (2 mM) | 14.1 ± 0.9 |
| 7.6 ± 0.2 | |
| Phosphoramidon (10 μM) | 4.3 ± 0.4 |
Comparison of the substrate specificity of PepS with those of NEP, ECE-1, and Zmp1a.
| Substrate | Sequences | Hydrolyzed peptide bonds | |||
|---|---|---|---|---|---|
| PepS | NEP | ECE-1 | Zmp1 | ||
| A1APL4 | No activity | ND | ND | ND | |
| Y1PLG4 | No activity | ND | ND | ND | |
| F1SPFR5 | P3-F4 | ND | ND | ND | |
| Enkephalin | Y1GGFM5 | G3-F4 | G3-F4 | ND | ND |
| Bradykinin | R1PPGFSPFR9 | P7-F8 | P7-F8 | P7-F8 | G4-F5 P7-F8 |
| Angiotensin I | D1RVYIHPFHL10 | Y4-I5 P7-F8 | Y4-I5 P7-F8 | V3-Y4 Y4-I5 P7-F8 | Y4-I5 P7-F8 H9-L10 |
| Substance P | R1PKPQQFFGLM11 | P4-Q5 Q5-Q6 Q6-F7 F7-F8 F8-G9 G9-L10 L10-M11 | Q6-F7 F7-F8 G9-L10 | Q6-F7 F7-F8 G9-L10 | Q6-F7 F7-F8 G9-L10 |
| Neurotensin | pE1LYENKPRRPYIL13 | L2-Y3 Y11-I12 | P10-Y11 Y11-I12 | L2-Y3 P10-Y11 | P10-Y11 Y11-I12 |
| Oxidized insulin B chain | F1VNQHLC(SO3H)GSH10LVEALYLVC(SO3H) G20ERGFFYTPKA30 | H5-L6 G8-S9 L11-V12 A14-L15 Y16-L17 L17-V18 G23-F24 F24-F25 F25-Y26 T27-P28 | H5-L6 H10-L11 L11-V12 A14-L15 L15-Y16 Y16-L17 L17-V18 G23-F24 F24-F25 F25-Y26 | H10-L11 L11-V12 E13-A14 A14-L15 L15-Y16 Y16-L17 T27-P28 | ND |
| Big ET-1 (human) | C1SCSSLMDKE10CVYFCHLDII20WVNTPEHVVP30YGLGSPRS38 (Disulfide bonds between C1 and C15/C3 and C11) | No activity | ND | W21-V22 | ND |